352 related articles for article (PubMed ID: 7687062)
21. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Ferrer C; Giolitti A; Guelfi M; Rotondaro L; Warner FJ; Maggi CA
J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554
[TBL] [Abstract][Full Text] [Related]
22. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
[TBL] [Abstract][Full Text] [Related]
23. Role of tachykinin NK1 and NK2 receptors in allergen-induced early and late asthmatic reactions, airway hyperresponsiveness, and airway inflammation in conscious, unrestrained guinea pigs.
Schuiling M; Zuidhof AB; Zaagsma J; Meurs H
Clin Exp Allergy; 1999 Jun; 29 Suppl 2():48-52. PubMed ID: 10421822
[TBL] [Abstract][Full Text] [Related]
24. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
Goso C; Astolfi M; Parlani M; Manzini S
Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
[TBL] [Abstract][Full Text] [Related]
25. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
26. Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists.
Beaujouan JC; Heuillet E; Petitet F; Saffroy M; Torrens Y; Glowinski J
Br J Pharmacol; 1993 Mar; 108(3):793-800. PubMed ID: 7682138
[TBL] [Abstract][Full Text] [Related]
27. Autoradiographic mapping of pulmonary NK1 and NK2 tachykinin receptors and changes after repeated antigen challenge in guinea pigs.
Mak JC; Astolfi M; Zhang XL; Evangelista S; Manzini S; Barnes PJ
Peptides; 1996; 17(8):1389-95. PubMed ID: 8971936
[TBL] [Abstract][Full Text] [Related]
28. Characterization of tachykinin NK2 receptor on dog proximal colon. Antagonism by MEN 10,627 and SR 48,968.
Parlani M; Conte B; Cirillo R; Manzini S
Eur J Pharmacol; 1996 Dec; 318(2-3):419-24. PubMed ID: 9016933
[TBL] [Abstract][Full Text] [Related]
29. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
30. The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor.
Bhogal N; Donnelly D; Findlay JB
J Biol Chem; 1994 Nov; 269(44):27269-74. PubMed ID: 7961636
[TBL] [Abstract][Full Text] [Related]
31. Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats.
Julia V; Morteau O; Buéno L
Gastroenterology; 1994 Jul; 107(1):94-102. PubMed ID: 7517374
[TBL] [Abstract][Full Text] [Related]
32. Tachykinin NK2 receptors: characterization in the rat small intestine by the use of a peptide agonist and a nonpeptide antagonist as radioligands.
Renzetti AR; Criscuoli M; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):139-44. PubMed ID: 9228201
[TBL] [Abstract][Full Text] [Related]
33. Tachykinin effects on bladder activity in conscious normal rats.
Ishizuka O; Mattiasson A; Andersson KE
J Urol; 1995 Jul; 154(1):257-61. PubMed ID: 7539864
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon.
Warner FJ; Comis A; Miller RC; Burcher E
Br J Pharmacol; 1999 Jul; 127(5):1105-10. PubMed ID: 10455255
[TBL] [Abstract][Full Text] [Related]
35. Characterization of tachykinin receptors in ferret trachea by peptide agonists and nonpeptide antagonists.
Geppetti P; Bertrand C; Bacci E; Huber O; Nadel JA
Am J Physiol; 1993 Aug; 265(2 Pt 1):L164-9. PubMed ID: 7690189
[TBL] [Abstract][Full Text] [Related]
36. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
[TBL] [Abstract][Full Text] [Related]
37. In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist.
Maggi CA; Patacchini R; Giuliani S; Giachetti A
Eur J Pharmacol; 1993 Mar; 234(1):83-90. PubMed ID: 8386095
[TBL] [Abstract][Full Text] [Related]
38. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors.
Tremblay L; Kemel ML; Desban M; Gauchy C; Glowinski J
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11214-8. PubMed ID: 1280822
[TBL] [Abstract][Full Text] [Related]
39. Aerosolized tachykinin antagonists inhibit pentamidine-induce bronchoconstriction in guinea pigs.
Jarreau PH; Harf A; Boyer V; Macquin-Mavier I
Fundam Clin Pharmacol; 1996; 10(6):518-23. PubMed ID: 8985721
[TBL] [Abstract][Full Text] [Related]
40. Activity of nonpeptide tachykinin antagonists on neurokinin a induced contractions in dog urinary bladder.
Rizzo CA; Hey JA
J Urol; 2000 Jun; 163(6):1971-4. PubMed ID: 10799241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
